What a Maturing GLP-1 Market Reveals About Modern Drug Markets and Their Future | Milbank Memorial Fund
MilbankTopic alignment 90
The scale and ubiquity of GLP-1s give them a rare ability to illuminate the strengths and weaknesses of US drug markets and, increasingly, to reshape those markets.
Filed under
- GLP-1 cost managementmatch 90
How to measure the long-term value of GLP-1s within employer healthcare costs
HFMATopic alignment 92
Medicare Plans Rarely Cover Anti-Obesity Drugs for Other FDA-Approved Purposes
USC SchaefferTopic alignment 95
Digital Health’s GLP-1 Strategy: “You Didn’t Come for the Drug. You Came for Health”
MedCity NewsTopic alignment 86
#AHA26: Boehringer to seek approval of obesity shot, but gaining market share could be tricky
Endpoints NewsTopic alignment 86